within Pharmacolibrary.Drugs.ATC.V;

model V03AE01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 15000 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Polystyrene sulfonate is an ion-exchange resin used to treat hyperkalemia (elevated potassium levels in the blood). It exchanges sodium or calcium ions for potassium ions in the intestine, promoting the elimination of potassium from the body. It has been widely used for the acute and chronic treatment of hyperkalemia, although newer agents are increasingly being recommended in some guidelines.</p><h4>Pharmacokinetics</h4><p>There are no published studies describing plasma pharmacokinetic parameters of polystyrene sulfonate, as the drug is not absorbed systemically; its activity is limited to the gastrointestinal tract. Parameters such as bioavailability, volume of distribution, clearance, and systemic absorption rates are generally not applicable or reported for this drug.</p><h4>References</h4><ol><li><p>Montaperto, AG, et al., &amp; Symoniak, MR (2016). Patiromer: a clinical review. <i>Current medical research and opinion</i> 32(1) 155–164. DOI:<a href=&quot;https://doi.org/10.1185/03007995.2015.1106935&quot;>10.1185/03007995.2015.1106935</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26456884/&quot;>https://pubmed.ncbi.nlm.nih.gov/26456884</a></p></li><li><p>Shepherd, G, et al., &amp; Burstein, AH (2000). Efficacy of the cation exchange resin, sodium polystyrene sulfonate, to decrease iron absorption. <i>Journal of toxicology. Clinical toxicology</i> 38(4) 389–394. DOI:<a href=&quot;https://doi.org/10.1081/clt-100100948&quot;>10.1081/clt-100100948</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10930055/&quot;>https://pubmed.ncbi.nlm.nih.gov/10930055</a></p></li><li><p>Sharma, S, et al., &amp; Mishra, PR (2015). Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 69 51–60. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2014.11.012&quot;>10.1016/j.ejps.2014.11.012</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25559064/&quot;>https://pubmed.ncbi.nlm.nih.gov/25559064</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V03AE01;
